论文信息 - Asciminib and ponatinib exert synergistic anti-neoplastic effects on CML cells expressing BCR-ABL1 T315I-compound mutations. - 字舞流文

Asciminib and ponatinib exert synergistic anti-neoplastic effects on CML cells expressing BCR-ABL1 T315I-compound mutations.

T. Lion | G. Stefanzl | P. Valent | W. Sperr | K. Gleixner | I. Sadovnik | Yüksel Filik | G. Eisenwort | K. Byrgazov | J. Mayer | Mathias Schneeweiss-Gleixner | Lina Degenfeld-Schonburg | Daniela Berger | Christina Schewzik | D. Berger | M. Schneeweiss-Gleixner